Why Psychedelic Research Conferences Matter

The scientific study of psychedelic substances has undergone a dramatic resurgence since the early 2000s. After decades of regulatory restrictions that severely limited research, institutions including Johns Hopkins University, Imperial College London, and the University of Zurich have reopened rigorous investigation into compounds such as psilocybin, ayahuasca, MDMA, LSD, and mescaline. Conferences and academic events have become essential infrastructure for this renaissance — providing the spaces where findings are presented, debated, refined, and translated into clinical practice.

Psychedelic research conferences serve multiple functions that no other format can replicate. They enable direct exchange between researchers working in different disciplines — connecting the neuroscientist studying serotonin receptor pharmacology with the anthropologist documenting indigenous ceremonial practices, or the clinical psychiatrist running depression trials with the policy analyst tracking regulatory developments. This interdisciplinary dialogue is not merely useful; it is essential for a field that spans pharmacology, psychology, neuroscience, anthropology, ethics, law, and public health.

Conferences also serve a quality-control function. The peer scrutiny that occurs when researchers present their work to knowledgeable audiences helps maintain scientific rigor and identifies weaknesses in methodology, interpretation, or conclusions. In a field attracting significant public interest and investment, this critical function is particularly important for distinguishing sound science from speculation.

The Major Psychedelic Research Conferences

Several established conferences form the backbone of the psychedelic research calendar. Each serves a distinct role within the broader ecosystem of scientific communication and professional development.

ICPR — Interdisciplinary Conference on Psychedelic Research

Europe's leading psychedelic research conference, organized by the OPEN Foundation and held biennially in the Netherlands. The 7th edition takes place June 4–6, 2026 at PHIL Haarlem. ICPR brings together researchers, clinicians, and scholars for presentations spanning neuroscience, clinical trials, anthropology, and policy.

Read Full Guide →

Breaking Convention

Europe's largest conference on psychedelic consciousness, held biennially in the United Kingdom since 2011. Breaking Convention uniquely integrates academic research with art, cinema, philosophy, and cultural programming. The next event is a One-Day Summit on May 16, 2026 at Woolwich Works, London.

Read Full Guide →

Other Notable Conferences and Events

Beyond ICPR, the psychedelic research landscape includes several other significant gatherings. Psychedelic Science, organized by the Multidisciplinary Association for Psychedelic Studies (MAPS), is among the largest events in the field and is typically held in the United States. Breaking Convention, based in the United Kingdom, combines academic research presentations with discussions of art, culture, and philosophy related to psychedelic experience. Various universities also host focused symposia on specific topics — for example, ayahuasca safety and pharmacology or the therapeutic applications of psilocybin.

The World Ayahuasca Conference, organized by ICEERS (International Center for Ethnobotanical Education, Research and Service), is particularly relevant to the traditions documented on this site. This conference focuses specifically on ayahuasca and brings together indigenous practitioners, researchers, policy experts, and community members to discuss the science, legal status, and cultural significance of the brew across different contexts.

What Psychedelic Conferences Cover

The scope of modern psychedelic research conferences reflects the breadth of the field itself. Typical programming includes clinical trial results for conditions such as treatment-resistant depression, PTSD, anxiety, and substance use disorders; neuroimaging studies examining how psychedelics affect brain function and connectivity; ethnobotanical research documenting traditional use of plant medicines across cultures; safety and pharmacology data relevant to responsible clinical application; policy and regulatory developments affecting research and access; ethical considerations in psychedelic research and therapy; and qualitative research exploring subjective experience and its therapeutic relevance.

Many conferences also include workshop days offering in-depth training on specific topics — such as therapeutic modalities, integration practices, or specialized research methodologies. These workshops provide practical professional development that complements the broader scientific programming.

The Role of Conferences in Advancing Psychedelic Science

The contribution of conferences to the progress of psychedelic research extends beyond the immediate exchange of information. They serve as catalysts for collaboration, often leading to multi-site research partnerships, co-authored publications, and shared methodological standards. They provide visibility for early-career researchers, who benefit from the opportunity to present their work and receive feedback from established scientists. And they create a record of the field's development — conference proceedings and abstracts collectively document the trajectory of psychedelic science.

For members of the public interested in psychedelic research, conferences also provide a reliable way to access current scientific thinking on these substances. Rather than relying on media summaries or social media, attending or following conference proceedings offers direct access to the nuances and caveats that researchers themselves emphasize — a particularly important distinction in a field where public interest often outpaces scientific certainty.

Frequently Asked Questions About Psychedelic Conferences

What are the major psychedelic research conferences?

The most prominent psychedelic research conferences include ICPR (Interdisciplinary Conference on Psychedelic Research) held biennially in Europe by the OPEN Foundation, Psychedelic Science organized by MAPS in the United States, and Breaking Convention in the United Kingdom. Universities and research institutes also host specialized academic symposia throughout the year.

Who attends psychedelic research conferences?

Attendees typically include academic researchers, clinical psychologists, psychiatrists, neuroscientists, pharmacologists, anthropologists, policy analysts, therapists, and students. Many conferences also welcome members of the public with a genuine interest in psychedelic science and its cultural dimensions.

Why are psychedelic conferences important for plant medicine research?

Conferences are critical venues for presenting new research, building interdisciplinary collaboration, shaping regulatory and policy discussions, and translating laboratory findings into clinical applications. They also provide a platform for discussing the cultural, ethical, and safety dimensions of psychedelic use, ensuring that scientific progress is informed by multiple perspectives.